Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral Toxicity”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableStudy completedNCT03423641
What this trial is testing

An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kaiser Permanente 33,808
Testing effectiveness (Phase 2)Study completedNCT03251144
What this trial is testing

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

Who this might be right for
HIV/AIDSAntiviral ToxicityAntiviral Drug Adverse Reaction+1 more
University of California, Los Angeles 26
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07363031
What this trial is testing

Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy

Who this might be right for
Oral MucositisHead and Neck Cancer (H&N)Radiotherapy Side Effects
Instituto Oncoclinicas 84
Testing effectiveness (Phase 2)Study completedNCT00594880
What this trial is testing

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

Who this might be right for
HIV Infections
The Wistar Institute 23
Testing effectiveness (Phase 2)Ended earlyNCT00122577
What this trial is testing

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 50
Early research (Phase 1)Study completedNCT00000735
What this trial is testing

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Post-approval studies (Phase 4)Looking for participantsNCT05626530
What this trial is testing

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionsInfection in Solid Organ Transplant RecipientsNeutropenia+1 more
Tufts Medical Center 25
Post-approval studies (Phase 4)Study completedNCT04904614
What this trial is testing

Letermovir Use in Heart Transplant Recipients

Who this might be right for
Cytomegalovirus DiseaseCytomegalovirus InfectionsHeart Transplant Infection+2 more
Tufts Medical Center 32
Early research (Phase 1)Study completedNCT00000713
What this trial is testing

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT01433289
What this trial is testing

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

Who this might be right for
HIV Infection
Baylor College of Medicine 23